Raman imaging is an optical imaging modality that holds promise for both preclinical and clinical cancer imaging 1,2 . Raman imaging is based on an inelastic interaction of light with matter. Although most photons scatter elastically (i.e., Rayleigh scattering), ˜1 in 10 7 photons either loses (i.e., Stokes) or gains energy (i.e., anti-Stokes) by causing vibrational transitions within a molecule in a process known as Raman scattering 3 . As these vibrational transitions are related to the respective molecular bonds, they are unique to the molecule and generate distinct, fingerprint-like Raman spectra. Label-free Raman imaging is currently being explored clinically to discriminate healthy tissues from abnormal tissues based on differences in Raman fingerprints, particularly for cancer screening of the skin, cervix and gastrointestinal tract 2 . However, as only a small fraction of the photons are Raman scattered, intrinsic Raman imaging requires long acquisition times. Accordingly, applications that require near real-time imaging must use a means to amplify the signal intensity of the Raman spectra being tracked. One means of accomplishing this is to introduce a pump laser that stimulates enhanced emission of Raman scattering 4, 5 . This process, called stimulated Raman scattering, shows promise for clinical applications, but the instrumentation required is not widely available. The other, more common approach to enable rapid in vivo Raman imaging is to introduce exogenous contrast agents that exhibit Raman spectra many orders of magnitude greater than any intrinsic signal 6, 7 . These contrast agents exploit a phenomenon known as surface-enhanced Raman scattering (SERS), wherein a noble metal nanoparticle acts as an antenna to amplify the Raman scattering intensity of molecules adsorbed on its surface. The magnitude of this amplification is highly dependent on the properties of the Raman scattering molecule (called a 'Raman reporter' molecule), the number of molecules that are directly adsorbed on the nanoparticle surface and the size of the nanoparticle core, with 50-to 60-nm gold nanoparticles providing the strongest enhancements 8, 9 . In this protocol, we describe how to prepare, characterize and conjugate SERRS nanoparticles to enable molecular imaging of lesions in preclinical cancer models using Raman imaging.
of the Raman fingerprint. Unlike other protocols [14] [15] [16] , our re-designed silica encapsulation protocol obviates the need for stabilizing polymers or auxiliary surface primers at the gold surface, thereby promoting increased surface availability for adsorption of resonant Raman reporter molecules 13 .
Both components proved critical in achieving orders-ofmagnitude better limits of detection because the electromagnetic 'antenna' effect provided by the gold core falls off with distance according to an r −12 dependence, and the SERS selection rules require electronic coupling between the reporter molecules and the nanoparticle surface for optimal enhancement to Raman scattering 13 . Last, an increase in the affinity of the resonant Raman reporter for the gold surface by incorporation of sulfur-containing functional groups such as thiophenes resulted in a reduction in the limit of detection by another order of magnitude 9 . Collectively, the above-described improvements afforded SERRS nanoparticles with attomolar (10 −18 M) detection limits under conditions amenable to in vivo imaging 9 .
Applications of SERRS nanoparticles
Nanotechnology holds great promise for cancer diagnostics and therapy. The (sub)femtomolar (≤10 −15 M) limits of detection of SERRS nanoparticles, and the straightforward synthesis and surface modification described in this protocol make SERRS nanoparticle-based Raman imaging an ideal platform for studying the interaction of nanoparticles with biological systems. As we were particularly interested in early and comprehensive cancer detection, we administered the optimized SERRS nanoparticles i.v. into a variety of mouse models bearing extracranial tumors. We had hypothesized previously that the increased sensitivity of the new generation of SERRS nanoparticles would overcome the barrier that previously prevented us from universal tumor imaging based on the EPR effect alone. This hypothesis was now confirmed in vivo, as the new SERRS nanoparticles, in their nontargeted form (i.e., poly(ethylene glycol) coating only), indeed enabled detection of tumors in all tested preclinical models, including sarcomas and breast, prostate and pancreatic cancer 13 . Moreover, we found that these nontargeted nanoparticles also delineated precancerous lesions after i.v. administration 13 . This is of great clinical relevance because at this stage the patient would still be amenable to therapeutic intervention with curative intent. Another clinically relevant application is the use of SERRS nanoparticle-guided resection, particularly in cancers for which there is no room for wide safety margins, such as glioblastoma or pancreatic cancer. We have shown that SERRS nanoparticles selectively accumulate in tumors and have high tumor-to-background ratios. In this way, SERRS nanoparticle-based Raman imaging provided accurate delineation of the tumors. It has also enabled detection of lymph node metastases in a preclinical prostate cancer model 17 . Clinical Raman imaging endoscopes have been developed and have been tested preclinically, even in human patients 18 . This, in combination with the facts that (i) the SERRS nanoparticles produced with this protocol consist of inert materials, (ii) other Raman nanoparticles of similar size and material composition have been shown to be nontoxic 19 and (iii) other gold or gold-silica nanoparticles have already advanced to clinical trials, suggests a viable path toward clinical translation of contrast-enhanced Raman imaging for cancer detection 20 .
As different 'flavors' of SERRS nanoparticles can be produced that have equally low limits of detection but generate distinct fingerprint-like Raman spectra, SERRS-based Raman imaging offers tremendous capabilities for multiplexing. This, in combination with the straightforward silica surface modification of SERRS nanoparticles, allows for rapid and efficient conjugation of targeting moieties such as antibodies, nanobodies, peptides and small molecules to enable actively targeted molecular imaging 9, 21 . SERRS nanoparticles targeted toward widely established diagnostic markers can be applied ex vivo or in vitro to inform rapidly on the molecular profile of resected tissue or tumor cells. For instance, following tumor resection, the tumor can be surveyed with Raman imaging ex vivo to determine the margin status based on SERRS-signal positivity. Alternatively, the resected tissue could be incubated ex vivo with different flavors of SERRS nanoparticles targeted toward widely established diagnostic markers such as EGFR, HER2, MUC1 and EpCAM to provide an immediate molecular profile of the tumor 22, 23 . Ratiometric Raman imaging of breast cancer lumpectomy tissue has demonstrated the viability of this multiplexed approach for ex vivo applications 23 , and the ability to discriminate tumor A431 cells from nontumor 3T3 2.2 cells validated the utility of SERS multiplexing in vitro 22 . Multiplexed SERS nanoparticles have also been used to identify circulating tumor cells in unprocessed human blood 24 .
Last, SERRS nanoparticles have or can be given multimodal imaging properties 6 . For instance, the gold nanoparticle core serves as a contrast agent for computed tomography (CT) and optoacoustic imaging, and the silica shell can be coated with gadolinium for contrast in magnetic resonance imaging (MRI) 6 . In addition, the high affinity of silica for radioisotopes such as 89 Zr and 68 Ga can enable whole-body imaging capabilities using positron-emission tomography (PET) 25, 26 . Apart from detection of premalignant and malignant lesions, nanoparticles have been shown to accumulate in atherosclerotic plaques and in ischemic lesions following myocardial infarction and therefore can have an important role in cardiovascular disease imaging as well 27, 28 .
Comparisons with other methods
Many methods exist for imaging cancer in vivo, each with qualities that make them advantageous for certain applications and disadvantageous for others. Well-established modalities include PET, MRI and ultrasound imaging 29, 30 . These techniques are preferable to optical approaches for deep tissue imaging and preoperative staging. Optical imaging is generally better suited to applications that require high spatial resolution, such as intraoperative detection of small tumor deposits to facilitate complete surgical resection. Among optical technologies, fluorescence imaging has so far been the most widely used 31 . However, background tissue fluorescence (i.e., autofluorescence) can lead to false-positive signals, and fluorescent contrast agents suffer from rapid degradation during imaging (i.e., photobleaching). SERRS nanoparticles currently offer the lowest limits of detection (i.e., greatest sensitivity) and demonstrate stability with respect to photobleaching, making them ideal candidates for intraoperative imaging 13, 32 .
Several alternative protocols exist for the preparation of SERRS nanoparticles. The primary advantage of our method is the very low limit of detection, which to our knowledge is currently unmatched. This is afforded by the optimized metal-molecule system. The gold nanoparticle cores used in this protocol are not stabilized by auxiliary agents such as surfactants or polymers. Such stabilization inhibits binding of Raman reporter molecules at the gold surface. Current alternative protocols rely upon, for example, thiolated PEG 16, [33] [34] [35] , polyvinylpyrrolidone 36 , mercaptoundecanoic acid 37 or SDS and protein 38 , to provide sufficient stability to the gold nanoparticle core such that it can withstand the destabilizing effect of Raman reporter molecules adsorbing to the surface. The cost of stabilizing the gold surface before addition of the reporter molecules is that less of the surface is available for binding, which can decrease the SERS intensity of the final nanoparticle construct by orders of magnitude.
Instead of stabilizing the gold nanoparticles with surfactants or polymers before reporter molecule addition, we perform a singlestep reaction that requires no auxiliary surface priming molecules.
This approach relies on a careful manipulation of the encapsulation kinetics (i.e., silica shell formation) such that molecular clusters of silica begin condensing onto the metal-molecule interface precisely as the binding of reporter molecules destabilizes the colloidal dispersion. As silica has relatively low affinity for the gold surface, it does not substantially displace the Raman reporter molecules, which have a higher affinity for the gold surface. Continued growth of the silica shell imparts lasting colloidal stability without decreasing the intensity of the SERRS signal. We quench the silica growth at will, such that we can promote fast encapsulation kinetics while preventing unwanted formation of free silica nanoparticles (i.e., without gold nanoparticle cores) yielding narrowly dispersed SERS nanoparticle preparations with (sub)femtomolar limits of detection.
Experimental design
The workflow for preclinical contrast-enhanced Raman imaging of cancer using SERRS nanoparticles is depicted in Figure 1 . A schematic representation of SERRS nanoparticle synthesis, which is described in this protocol, is shown in Figure 2 .
We use a modified Turkevich method to synthesize gold nanoparticles with a size ~60 nm 39 . We obtain nanospheres by rapidly adding a citrate solution to a stirring, boiling solution of gold chloride. Alternatively, to obtain star-shaped gold nanoparticles of similar size, we rapidly add a gold chloride solution to an icecold solution of ascorbic acid (AA). Recently, we demonstrated that yet even other shapes, such as plates and nanorods, can be obtained by tuning the reaction kinetics of the gold reduction 40 . In both cases, we collect the synthesized gold nanoparticles by centrifugation and dialyze the gold nanoparticles to remove any residual salts. The size and shape of the synthesized nanoparticles can be measured on a transmission electron microscope (TEM). The hydrodynamic size and concentration can be measured using nanoparticle tracking analysis (NTA). The NTA measurements are complementary to the TEM images, as the TEM provides information on the size, shape and integrity of the nanoparticles, whereas the NTA provides the concentration and size distribution of the nanoparticle dispersion.
We encapsulate the dialyzed gold nanoparticles with silica using a modified Stöber procedure 41 . Commercially available gold nanoparticle dispersions are synthesized using proprietary procedures and often auxiliary agents are added to stabilize these gold nanoparticle dispersions. These are incompatible with the current protocol and therefore commercially available gold nanoparticle dispersions may not provide the expected results using this protocol. We perform silica encapsulation in the presence of a Raman reporter that is resonant with the excitation laser wavelength, which is 785 nm in the current protocol. Unlike other protocols [14] [15] [16] , the current SERRS nanoparticle synthesis protocol obviates the need for any commonly used auxiliary gold surface priming or stabilizing agents such as (3-mercaptopropyl) trimethoxysilane (MPTMS), (3-aminopropyl)-trimethoxysilane (APTMS), albumin or PEG-thiol, meaning silica shells can be grown directly from the gold nanoparticles, affording substantially higher SERRS signal sensitivities and lower limits of detection 13 . To prevent gold nanoparticle aggregation, the gold nanoparticles do need to be dialyzed before silica encapsulation to remove any residual salts 42 . Furthermore, we have recently shown that, unlike kosmotropic counteranions such as chloride, cationic dyes with chaotropic counteranions such as iodide, tetrafluoroborate (BF 4 − ), hexafluorophosphate (PF 6 − ) and perchlorate (ClO 4 − ) stabilize the colloidal dispersion, thereby minimizing gold nanoparticle aggregation during silica encapsulation 9 and yielding narrowly dispersed SERRS nanoparticles. Although we monitored the integrity of the nanoparticle dispersions by eye or by UV/visible spectroscopy for the spherical gold nanoparticles, we recommend using TEM and NTA to validate SERRS nanoparticle integrity and size distribution, and to measure the concentration. Furthermore, we performed Raman spectroscopy to measure the intensity of the signal generated by the SERRS nanoparticles.
We functionalize the surface of SERRS nanoparticles by heating them in the presence of MPTMS or APTMS to introduce thiol or amine functionality, respectively. However, as the introduction of amine groups switches the zeta potential of the SERRS nanoparticles from negative to positive, the SERRS nanoparticles readily adsorb to the plastic container. In the current protocol, therefore, only surface functionalization of SERRS nanoparticles with MPTMS is described.
Once we have functionalized the SERRS nanoparticles with MPTMS, we use the introduced thiols for conjugation of PEG (Steps 17-21) or targeting moieties (e.g., antibodies; Steps [17] [18] [19] [20] [21] to the SERRS nanoparticle surface using maleimide-functionalized PEG or heterobifunctional maleimide-functionalized linkers, respectively. We re-disperse the functionalized SERRS nanoparticles in 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) (pH 7.3).
We evaluate the serum stability of the PEGylated SERRS nanoparticles in terms of colloidal stability and Raman signal intensity using NTA/TEM and Raman spectroscopy, respectively.
For Raman imaging, we inject the SERRS nanoparticles i.v. via the tail vein of tumor-bearing animals. After 3-18 h, we anesthetize or sacrifice the SERRS nanoparticle-injected, tumor-bearing animal and we place the animal on the platform of the Raman imaging system. As described in this protocol, we use a commercially available Raman imaging system (InVia, Renishaw). We perform a raster scan of the region of interest and generate a Raman image using a direct classical least square (DCLS) algorithm. We resect SERRS-positive tissue and process for histopathological examination. Following resection, another Raman scan can be performed to validate whether all the SERRS-positive tissue has adequately been removed.
Limitations
Although the described properties of SERRS nanoparticles, such as high signal sensitivity and specificity, are highly sought-after features for molecular imaging agents, in both preclinical and clinical settings, currently Raman imaging is not widely applied. Important underlying reasons are that, unlike other optical imaging modalities such as fluorescence, SERRS nanoparticles are not commercially available and instrumentation for Raman imaging is currently not widespread. Our protocol offers a stepby-step procedure that yields injectable (targeted) SERRS nanoparticles within 6 h. Regarding instrumentation, the instrument components are widely available and step-by-step protocols exist to build affordable Raman imaging systems 18, 43, 44 that can be tailored to a specific (clinical) application such as endoscopy. Further, the SERRS nanoparticles described in this protocol are optimized for detection using a 785-nm excitation laser. Even at this laser wavelength in the near-infrared (NIR) window, tissue penetration depth is limited to several millimeters. This limitation can be addressed by spatially offset Raman spectroscopy (SORS) 45 , which is based on the detection of Raman-shifted photons offset from the excitation position. Application of SORS for detection of SERRS nanoparticles, which is known as surface-enhanced spatially offset Raman scattering, reportedly enables the detection of SERRS nanoparticles at a tissue depth of several centimeters 46 . Aqua regia Prepare the minimum volume (e.g., 10 ml) of aqua regia needed by carefully adding one part concentrated nitric acid to three parts concentrated hydrochloric acid. Aqua regia should be freshly made. ! cautIon Aqua regia is highly corrosive. Wear appropriate acid-resistant gloves, lab coat and eye protection and work in a fume hood when handling aqua regia. Do not store aqua regia for an extended length of time. Dispose of leftover aqua regia by pouring it over a large amount of ice. This mixture may be neutralized with a saturated sodium bicarbonate solution or 10% (wt/vol) sodium hydroxide. The neutralized solution may then be safely poured down the drain. Sodium hydroxide Prepare 50 ml of 0.1 M NaOH by dissolving 0.2 g of NaOH in 50 ml of deionized water. Sodium hydroxide solutions can be stored in plastic containers for at least a year at room temperature. ! cautIon Sodium hydroxide is corrosive. Wear gloves and eye protection when handling it. Resonant Raman reporter: IR780 and IR792 stock solutions Dissolve 3.1 mg of IR-780 perchlorate or 26.5 mg of IR-792 perchlorate in 1.0 ml of DMF to obtain 5 mM or 37.5 mM stock concentrations, respectively, of the resonant Raman reporters. The stock solutions can be stored for at least a week in the dark at 4 °C. ! cautIon DMF is toxic. Limit exposure by wearing gloves, and work in a fume hood when handling it.
MaterIals

REAGENTS
• • proceDure synthesis of 60-nm gold nanoparticles • tIMInG 2 h 1| Follow option A to synthesize spherical gold nanoparticles and option B to synthesize star-shaped gold nanoparticles. For Raman imaging applications, the spherical gold nanoparticles perform similarly to the star-shaped gold nanoparticles in terms of signal sensitivity, limit of detection and tumor accumulation. Unlike the star-shaped gold nanoparticles, which have an absorption maximum in the NIR wavelength range, the absorption maximum of monomeric spherical gold nanoparticles is located at 540 nm, which red-shifts when the nanoparticles are aggregated. This allows visual monitoring of the colloidal stability during SERRS nanoparticle synthesis (Fig. 4) , which is very helpful, especially during optimization or evaluation of new resonant Raman reporters. Alternatively, by converting the absorbed NIR photons of the 785-nm excitation laser to heat via a process known as the photothermal effect, star-shaped gold nanoparticles enable Raman-guided photothermal therapy. Because the current protocol focuses on SERRS nanoparticles for contrast-enhanced Raman imaging, we mainly discuss applications for spherical gold nanoparticles; however, star-shaped nanoparticles can be used interchangeably. Maintain the stirring speed at 300 r.p.m. (Optional) A reflux condenser could be added to maintain a constant volume. ! cautIon The surface is hot. Avoid contact with the heated parts when not wearing heat-resistant gloves. (iii) Rapidly add 15 ml of 0.5% (vol/vol) sodium citrate solution. The color of the solution will go from yellow to black and finally to burgundy red. Leave it stirring for 10 min while heating. (iv) Let the dispersion cool down to ambient temperature, divide the dispersion among 20 50-ml centrifuge tubes and centrifuge the tubes at room temperature for 10 min at 5,000g. (v) Using a 50-ml pipette, carefully discard ~48.5 ml of the supernatant from each 50-ml tube without disrupting the pelleted gold nanoparticles. ! cautIon Aqua regia is highly corrosive. Avoid contact with aqua regia by working in a fume hood while wearing gloves, lab coat and eye protection. Always generate the minimal volume of aqua regia that is needed for a specific Mouse anesthesia by inhalation of isoflurane Use the volatile fluorocarbon isoflurane (1-4%), administered using a precision vaporizer (which has been calibrated and certified within the past 12 months) in an induction chamber, followed by use of a nose cone. Scavenge waste anesthetic gas by using an activated carbon canister. Confirm the depth of anesthesia by verifying an absence of response to ear, toe and/or tail pinch. Evaluate the response by monitoring withdrawal, as well as any increase or change in the respiratory rate and/or pattern.
EQUIPMENT SETUP Raman spectroscopy and imaging setup
We use an InVia Raman microscopy system (Renishaw) equipped with a 300-mW 785-nm diode laser and a 1-inch charge-coupled device (CCD) detector with a spectral resolution of 1.07 cm −1 for SERRS nanoparticle characterization and small-animal Raman imaging (Fig. 3) . We collect the Raman spectra through a 5× objective (Leica). We measure laser output at the microscope objective with a handheld laser power meter and have determined it to be 100 mW when the laser is running at 100% laser power. application. Dispose of leftover aqua regia by pouring it over a large amount of ice. This mixture may be neutralized with a saturated sodium bicarbonate solution or 10% (wt/vol) sodium hydroxide. The neutralized solution may then be safely poured down the drain.  crItIcal step Residual gold nanoparticles in the waste solutions generated in this section of the PROCEDURE can be recovered by treating the aqueous waste with an excess of sodium chloride to aggregate the gold nanoparticles. The precipitated aggregates can be collected, washed with water and recycled to gold chloride using aqua regia. All glassware also can be rinsed with aqua regia. ? trouBlesHootInG (vi) Immediately divide the dispersion among 20 50-ml centrifuge tubes and centrifuge the tubes in a prechilled centrifuge for 10 min at 5,000g at 4 °C.  crItIcal step It is important to keep the dispersion at 4 °C; otherwise, the nanostars will transform into spheres, which can be monitored by a transition from a dark blue to purple to eventually pink color of the dispersion. Only the dark blue dispersion produces narrowly disperse nanostars. (vii) Using a 50-ml pipette, carefully discard ~48.5 ml of the supernatant without disrupting the pelleted gold nanostars.
! cautIon Aqua regia is highly corrosive. Avoid contact with aqua regia by working in a fume hood while wearing gloves, lab coat and eye protection. Always generate the minimal volume of aqua regia that is needed for a specific application. Dispose of leftover aqua regia by pouring it over a large amount of ice. This mixture may be neutralized with a saturated sodium bicarbonate solution or 10% (wt/vol) sodium hydroxide. The neutralized solution may then be safely poured down the drain.  crItIcal step Residual gold nanoparticles in the waste solutions generated in this section of the PROCEDURE can be recovered by treating the aqueous waste with an excess of sodium chloride to aggregate the gold nanoparticles. The precipitated aggregates can be collected, washed with water and recycled to gold chloride using aqua regia. All glassware also can be rinsed with aqua regia.
Dialysis of 60-nm gold nanoparticles • tIMInG 5 d 2|
Collect, pool and transfer the remaining volume containing the gold nanoparticles to a 30-ml dialysis cassette (MWCO = 3.5 kDa). Remove the air from the dialysis cassette to maximize the surface area-to-volume ratio and place the dialysis cassette in a container containing 5 liters of deionized water and a magnetic stir bar. Place the container on a magnetic stirrer and stir overnight at 350 r.p.m. at ambient conditions. Replace the water daily for 5 d.
3|
Recover the dialyzed gold nanoparticle dispersion using a 10-ml pipette and transfer the dispersion to a 50-ml centrifuge tube.  crItIcal step TEM, NTA and Raman spectroscopy, as described in Step 22, can be performed on the nanoparticle dispersions to assess the size, shape and concentration of the nanoparticles.  pause poInt The 60-nm gold nanoparticles can be stored in deionized water at ambient conditions for at least 1 year at room temperature. synthesis of serrs nanoparticles • tIMInG 1 h 4| Prepare a basic dispersion of gold nanoparticles in isopropanol by adding 2.0 ml of dialyzed 60-nm gold nanoparticles (2.0 nM), 2.0 ml of deionized water and 600 µl of ammonium hydroxide to 30 ml of isopropanol to a 50-ml centrifuge tube and then vortexing the mixture.
5|
Prepare a solution of Raman reporter and silica precursor TEOS in isopropanol by adding 75 µl of 5 mM IR780 or 37.5 mM IR792 in DMF and 1.2 ml of TEOS to 9.0 ml of isopropanol and vortexing the mixture.
6|
Rapidly add the basic gold nanoparticle dispersion from Step 4 to the Raman reporter/TEOS solution from
Step 5 and place the reaction mixture in an incubator shaker for 15 min at 25 °C at 350 r.p.m. The dispersion should have a purplish color (Fig. 4) . A successful reaction generates a purple dispersion.  crItIcal step If the dispersion turns blackish purple or grayish blue (Fig. 4) , the gold nanoparticles are aggregating and the reaction should be repeated with fresh reagents. ? trouBlesHootInG 7| Transfer 22.5 ml of the reaction mixture to a new 50-ml centrifuge tube, add 27.5 ml of ethanol to both tubes to quench the silication reaction and centrifuge the quenched dispersions for 10 min at 4 °C at 5,000g.
8|
Using a 50-ml pipette, carefully remove all the supernatant and add 500 µl of ethanol to both tubes. Re-disperse the de novo-synthesized SERRS nanoparticles by placing the closed 50-ml tubes containing the SERRS nanoparticle pellets in a sonicator (5 s; amplitude 50). ! cautIon Close the tubes to prevent aerosol formation. Wear ear protection when performing sonication.
9|
Transfer the re-dispersed SERRS nanoparticles to 1.5-ml centrifugation tubes and centrifuge the dispersion for 5 min at 10,500g at room temperature in a microcentrifuge.
10|
Remove and discard the supernatant, add 1.0 ml of ethanol and re-disperse the SERRS nanoparticles using sonication.
11|
Repeat the wash steps (Steps 9 and 10) at least three times.  crItIcal step TEM, NTA and Raman spectroscopy, as described in Step 22, can be performed on the nanoparticles to assess the size, shape and concentration, as well as the SERRS spectrum and intensity, of the nanoparticle dispersions.  pause poInt The SERRS nanoparticles can be stored in ethanol for a couple of weeks at room temperature.
serrs nanoparticle surface modification • tIMInG 2.5 h 12| To 1.0 ml of 4 nM SERRS nanoparticles in ethanol, add 100 µl of MPTMS and 20 µl of ammonium hydroxide (28% (vol/vol)) and vortex. ! cautIon MPTMS has a very pungent odor. Work in a fume hood when handling MPTMS.
13|
Place the reaction mixture in a thermomixer for 2 h at 70 °C at 350 r.p.m.
14|
Centrifuge the dispersion at room temperature for 5 min at 10,500g. Remove and discard the supernatant, add 1.0 ml of ethanol and re-disperse the SERRS nanoparticles using sonication to wash the surface-modified SERRS nanoparticles.
15|
Repeat the wash step (Step 14) at least three times.
16|
Repeat the wash step (Step 14) at least three times with deionized water instead of ethanol.  crItIcal step TEM, NTA and Raman spectroscopy, as described in Step 22, can be performed on the nanoparticles to assess the size, shape and concentration, as well as the SERRS spectrum and intensity of the nanoparticle dispersions.  pause poInt The SERRS nanoparticles can be stored in deionized water for a couple of days at room temperature.
peGylation of 'conjugation-ready' serrs nanoparticles • tIMInG 2.5 h 17| Prepare a 1% (wt/vol) mal-PEG 2,000 dispersion in a 2-ml microcentrifuge tube by adding 10 mg of mal-PEG 2,000 to 1.0 ml of 10 mM MES buffer (pH 7.1).
20|
Remove and discard the supernatant, add 2 ml of deionized water and re-disperse the PEGylated SERRS nanoparticles using sonication.
21|
Repeat the wash steps (Steps 19 and 20) at least three times. After the last wash, re-disperse the PEGylated SERRS nanoparticles in 1.0 ml of filter-sterilized 10 mM MES buffer (pH 7.3), unless you wish to store them, in which case resuspend them in 1 ml of deionized water.  pause poInt The PEGylated SERRS nanoparticles (~4 nM) can be stored in 1.0 ml of deionized water for a couple of days at room temperature. Before injection, centrifuge the stored PEGylated SERRS nanoparticles, at room temperature for 5 min at 10,500g. remove the aqueous supernatant and re-disperse the PEGylated SERRS nanoparticles in an appropriate volume of the injection buffer (e.g., 10 mM MES (pH 7.3)) using sonication.
nanoparticle characterization 22| Perform TEM (option A), NTA (option B) and Raman spectroscopy (option C) on the nanoparticles to assess the size, shape and concentration, as well as the SERRS spectrum and intensity, of the nanoparticle dispersions. We advise performing TEM, NTA and Raman spectroscopy after each new SERRS nanoparticle batch synthesis to ensure reproducibility in terms of size, concentration and Raman signal intensity. In addition, you can assess the absorption spectrum of SERRS nanoparticle dispersions using UV/visible spectroscopy (option D) or in vitro characterization of the effect of serum components on SERRS nanoparticle stability (option E). Options A-C can also be performed at Steps 3, 11 and 16.
(a) teM characterization of the nanoparticles • tIMInG 1 h (i) Put a 1-µl drop of the dispersions onto a carbon-coated TEM grid and air-dry it at room temperature for 5-10 min (depending on the dispersant). (ii) Image the samples on a TEM (e.g., JEOL 1200ex-II; 80 kV). The spherical, bare gold nanoparticles (from Step 3) will appear spherical or slightly ellipsoid, with a mean diameter of 60 nm. The SERRS nanoparticles (Steps 11, 16, and 21) will appear as a dense core that is encapsulated by a less-dense layer of amorphous silica (Fig. 5) . The silica layer should measure 15-20 nm in thickness. If the layer appears thinner than expected or if there is no layer at all, repeat the procedure again but with freshly ordered (28% (vol/vol)) ammonium hydroxide. ! cautIon Ammonium hydroxide is corrosive. Wear gloves and eye protection when handling it. (ii) Place the 1,536-well plate onto the stage of the Raman microscopy system (Renishaw InVia).
(iii) Focus the laser on the sample. ! cautIon Ocular and skin exposure to laser radiation may pose a risk of eye injury and skin burns. Enclose the laser setup in a box and wear laser safety goggles at 785 nm when operating lasers. Only trained and licensed personnel should operate lasers. (iv) Measure the Raman spectrum in the wavenumber range of 500-1,650 cm -1 using a 1-s acquisition time at 0.05% laser power to prevent the CCD from being saturated. If the detector saturates, lower the laser output power. If the background is curved, this is due to fluorescence generated by the dye. Wash the SERRS nanoparticles with ethanol to remove any residual free resonant Raman reporter. If the problem persists, repeat the SERRS nanoparticle synthesis ? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG
Step 1 Step 22A, SERRS nanoparticle characterization using TEM: 1 h
Step 22B, SERRS nanoparticle characterization and concentration measurement using NTA: 15 min
Step 22C, Raman spectroscopy of SERRS nanoparticles: 15 min
Step 22D, determination of UV/visible absorption of SERRS nanoparticle dispersion: 15 min
Step 22E, in vitro characterization of the effect of serum components on SERRS nanoparticle stability: 48 h
Step 23A, examination of cellular uptake mechanisms of SERRS nanoparticles: 10 h
Step 23B, in vivo cancer imaging using SERRS nanoparticles: 6-26 h antIcIpateD results
Gold nanoparticle synthesis
The gold nanoparticle synthesis (Step 1A) will reproducibly yield spherical gold nanoparticles with a size of 60 nm (coefficient of variation: <1%; n = 3). The factors that are critical for obtaining 60-nm, spherical gold nanoparticles are the gold chloride/citrate ratio and the temperature of the reaction. A gold chloride/citrate ratio of 10:1 produces 60-nm gold nanoparticles. Decreasing this ratio will result in smaller gold nanoparticles, whereas increasing the ratio will result in larger gold nanoparticles. However, as the enhancement effect is the strongest for gold nanoparticles of 50-60 nm size 8 , we strongly discourage the use of other sizes, because this will affect the SERRS signal sensitivity and limits of detection. For the gold nanostars, it is important to maintain the temperature before dialysis at ≤4 °C to prevent the gold nanostars from transforming into spheres. This can be monitored visually, because the color of the gold nanostar dispersion will turn from blue to purple to red if the nanostars transform into spheres. However, once the gold nanostars have been dialyzed, they will remain stable at ambient conditions for prolonged periods of time.
serrs nanoparticle synthesis
Before synthesis, the basic 60-nm, spherical gold nanoparticle dispersion will have a pink color (Step 4; Fig. 4a ) and the resonant Raman reporter-containing solution has a green color (Step 5). After rapidly combining the two (Step 6), the resulting dispersion should appear purple (Fig. 4b) . However, if the resulting dispersion (
Step 11) appears grayish blue or black (Fig. 4c) , the gold nanoparticles have aggregated and the procedure described in Steps 4-11 should be repeated. Of note, visual monitoring is not possible for the nanostars during silica encapsulation, because aggregation causes a red-shift of the nanostars' localized surface plasmon resonance beyond the spectral sensitivity of the human eye (>700 nm). In the event of gold nanoparticle aggregation during silica encapsulation, decreasing the resonant Raman reporter concentration or longer dialysis of the gold nanoparticles will prevent aggregation. After centrifugation (Step 7), successful encapsulation of spherical or star-shaped gold nanoparticles will yield a red pellet or blue pellet, respectively, at the bottom of the centrifugation tubes, with a clear, green supernatant. The SERRS nanoparticle morphology and dispersity is assessed using TEM, NTA and UV/visible spectroscopy (Step 22 A-C). Successful SERRS nanoparticle synthesis results in monomeric nanoparticle species that appear as a dense gold core surrounded by a less dense silica shell measuring 15-20 nm on TEM (Fig. 5a) . If the silica shells appear thinner, replace the ammonium hydroxide solution with a fresh batch. The hydrodynamic diameter of the SERRS nanoparticles is centered on 100 nm, and the concentration should be ~4.0 nM, as measured by NTA (Fig. 5a) . A typical absorption spectrum of an synthesized SERRS nanoparticle dispersion has an absorption maximum ~540-550 nm (depending on the silica shell thickness and the size and shape of the gold nanoparticle core; Fig. 5a ). When the dispersion turns grayish blue or black during SERRS nanoparticle synthesis, large gold nanoparticle aggregates surrounded by silica are observed (Fig. 5b) . Large aggregates have hydrodynamic diameters of >200 nm and demonstrate an increase in absorption in the 700-to 900-nm wavelength range (Fig. 5b) . Aggregated nanoparticle dispersions should be discarded and should not be used for in vivo cancer imaging. If gold nanoparticle aggregation occurs during silica encapsulation, lower the dye concentrations. Use only cationic dyes with chaotropic counteranions such as iodide, tetrafluoroborate (BF 4 -), hexafluorophosphate (PF 6 -) and perchlorate (ClO 4 -) and avoid kosmotropic counter-anions such as chloride and fluoride. If the problem persists, re-dialyze the gold nanoparticle dispersion. Successful SERRS nanostar synthesis results in monomeric silica-coated gold nanostars with a hydrodynamic diameter centered ~100 nm, as measured by NTA and an absorption maximum in the NIR range (i.e., ~700 nm; Fig. 5c ).
In Figure 6 , the Raman spectra of two different flavors of SERRS nanoparticles are shown. SERRS nanoparticles with IR780 perchlorate as the resonant Raman reporter produce a spectrum with a diagnostic band at 950 cm −1 (Fig. 6a) , whereas SERRS nanoparticles with IR792 perchlorate as the resonant Raman reporter produce a diagnostic band at 1,200 cm −1 (Fig. 6b) . However, when the background is curved, residual free resonant Raman reporter is present in the SERRS nanoparticle dispersion, causing fluorescence. Wash the SERRS nanoparticles with ethanol to remove any residual free resonant Raman reporter. If the problem persists, repeat the SERRS nanoparticle synthesis procedure with less water present during the silica encapsulation. This will generate SESRS nanoparticles with thinner silica shells, which will ensure that the NIR fluorescent signal of the encapsulated resonant Raman reporters is quenched by the gold core. Furthermore, this will also prevent the generation of resonant Raman reporter-embedded free silica (without a gold core), which also produces a fluorescent signal. In addition, avoid using anionic resonant Raman reporters such as sulfonated NIR dyes (e.g., IR783 or ICG).
Surface modification is achieved by coating the SERRS nanoparticles with MPTMS at 70 °C for at least 1 h in a basic ethanolic solution. Following surface modification, the SERRS nanoparticles should be thoroughly washed to remove all residual MPTMS. Thiolation efficiency can be assessed using Ellman's reagent 48 . Typically, the thiolated SERRS nanoparticles are added to Ellman's reagent in a microcentrifuge tube and after an appropriate amount of time (i.e., 5-10 min) the samples are centrifuged at room temperature for 5 min at 5,000g. Subsequently, the supernatant is transferred to a 96-well microplate and the absorption is measured on a UV/visible spectrometer at 412 nm. Typically, the SERRS nanoparticles will contain on average 35,000-50,000 thiol groups per nanoparticle 49, 50 . Next, the introduced thiol functionality is used to conjugate PEG to afford nontargeted PEGylated SERRS nanoparticles or, in a similar manner, targeting-moiety-functionalized PEG linkers are used to afford targeted SERRS nanoparticles. When i.v. injected via tail vein into a tumor-bearing animal, the PEGylated SERRS nanoparticles target the tumor within several hours. Typically, no noticeable signs of discomfort or adverse reactions following injection of narrowly dispersed 100-nm PEGylated SERRS nanoparticles will be observed. To avoid any potential larger nanoparticle aggregates in the injectate, we recommend filtering a diluted (i.e., 1.0 nM) SERRS nanoparticle dispersion through a 0.22-µm filter before injection.
For Raman imaging in living animals, estimate and consider the needed imaging time in advance. For instance, if imaging will take <20 min, i.p. injection of a ketamine/ xylazine cocktail is sufficient to anesthetize the animal, whereas anesthetization using isoflurane is the preferred method for Raman imaging of longer duration. Make sure to lubricate the eyes with a lubricant (e.g., Duratears, Alcon), monitor the vital signs of the animal and adjust anesthesia accordingly. Raman imaging is highly dependent on the laser focus. An unfocused laser can lead to markedly decreased Raman signal intensity. Although this is less of an issue for samples with flat surfaces such as tissue blocks or well plates, the curvature of tissues in situ may lead to signal loss on the edge of the tissue where the laser is no longer in focus. Although this can be mitigated by performing multiple Raman scans at different focal planes, systems (or system updates) are available that focus the laser in realtime, avoiding signal loss due to out-of-focus issues.
As shown in Figure 7 13 , in situ Raman imaging of the prostate of a Hi-Myc mouse injected with SERRS nanoparticles identified a focal, SERRS-positive 'lesion 1' (Fig. 7a,  top) , which was graded as high-grade prostate intraepithelial neoplasia-a precursor lesion to prostate cancer-by a veterinary pathologist (Fig. 7a, bottom) . After Ramanguided resection of lesion 1, secondary Raman imaging was performed, followed by Raman-guided resection of lesions 2 and 3, which were found to be invasive carcinoma with squamous and mucous cell differentiation. Following resection 2, a final Raman scan was performed. Residual SERRS signal was found, and lesion 4 was identified, biopsied and confirmed to be invasive adenocarcinoma. As shown in Figure 7b , the diagnostic 950 cm −1 band of the SERRS nanoparticles was found in all identified premalignant and malignant prostate lesions, but not in normal prostate tissue (indicated by arrowhead 5).
Overall, the current protocol describes the synthesis of PEGylated SERRS nanoparticles that when administered i.v. in preclinical cancer models enable highly sensitive tumor detection independent of type and stage. Apart from biomedical research, our protocols will also be of interest to material scientists, because with minor modifications the same synthesis protocols could be applied to different metal nanoparticles or with different encapsulation materials such as, for instance, titanium oxide instead of silica, thereby opening entirely new avenues for applications in photocatalysis and photovoltaics [51] [52] [53] . High-grade PIN 500 700 900 1,100 1,300 1,500
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